Health Data Trends

New Clinician? Start Here

For a complete medical history overview with pathology, treatment history, and current status, see the 📋 Medical Summary Portfolio

Interactive visualizations of key biomarkers over time.

β-HCG Tumor Marker

The β-HCG (Beta Human Chorionic Gonadotropin) tumor marker is a critical indicator for monitoring germ cell tumors. Elevated levels indicate tumor activity, while declining levels suggest treatment effectiveness.

Current Status

Latest Value: 113 IU/L (November 22, 2025)
Reference Range: < 2 IU/L (currently HIGH)
Overall Progress: 70,482 → 113 IU/L (99.84% reduction from initial value)
Recent Trend: ⚠️ CRITICAL - Rapid rise from nadir (9 → 10 → 24 → 42 → 113)

Interactive Chart

Key Observations

Peak Period (March - July 2025) - Highest value: 240,422 IU/L (July 2, 2025) - Initial value: 70,482 IU/L (March 21) - Showed significant volatility with multiple peaks

Decline Phase (July - October 2025) - Sharp drop from 240,422 → 7,324 in August - Continued decline to lowest point: 9 IU/L (October 29) - 97% reduction from peak

Recent Activity (October - November 2025) - CRITICAL: Rapid progression from nadir - 9 → 10 → 24 → 42 → 113 IU/L - 24-day period: 9 IU/L (Oct 29) → 113 IU/L (Nov 22) - Nearly 13-fold increase from lowest point - Still 99.84% below initial value, but trending upward aggressively - Doubling every ~5 days - requires immediate clinical intervention

Clinical Context

β-HCG is used as a tumor marker in testicular germ cell tumors: - Raised levels seen in ~35% of non-seminomatous tumors - Seen in <20% of seminomatous tumors - Half-life of ~24-36 hours when declining - Persistent elevation suggests active disease - Values >100,000 IU/L considered very high risk

Next Steps

URGENT: Contact oncologist immediately - 13-fold increase from nadir (9→113) in 24 days
Immediate imaging - CT/PET scan to assess disease progression
Treatment escalation - Current protocol not controlling disease
Clinical consultation - Rapid rise after nadir indicates treatment resistance or refractory disease
Consider salvage therapy - High-dose chemotherapy, stem cell rescue, or alternative protocols

Comprehensive Biomarker Tracking

This multi-panel chart combines tumor markers, full blood count, and inflammatory markers for a complete health picture. Each biomarker can be toggled on/off by clicking its legend item.

What's Tracked

Tumor Markers - β-HCG - Primary tumor marker for testicular germ cell tumors

Full Blood Count - Platelets - Blood clotting function - White Blood Cells (WBC) - Immune system health - Red Blood Cells (RBC) - Oxygen transport - Hemoglobin - Anemia indicator
- Neutrophils - Infection defense - Lymphocytes - Immune response cells

Inflammatory Markers - CRP (C-Reactive Protein) - General inflammation indicator

Interactive Chart

How to Use

Click legend items to show/hide individual biomarkers
Hover over data points for detailed values
Zoom and pan to focus on specific time periods
Download chart as PNG using toolbar

Current Status Summary

β-HCG: 42 IU/L (HIGH - rising trend, requires urgent attention)
Platelets: 151 x10E9/L (Normal)
WBC: 0.90 x10E9/L (LOW - neutropenic)
RBC: 3.34 x10E12/L (LOW - anemia)
Hemoglobin: 10.1 g/dL (LOW - anemia)
Neutrophils: 0.43 x10E9/L (LOW - severe neutropenia)
Lymphocytes: 0.30 x10E9/L (LOW - lymphopenia)
CRP: 6.5 mg/L (ELEVATED - inflammation)

Overview

Visual analysis of biomarker changes over time to identify patterns and track progress.

Next: Treatments